Keeping Track: Exelixis, Sanofi Submit NDAs While AstraZeneca, Actelion Collect Approvals
The latest drug development news and highlights from our FDA Performance Tracker.
You may also be interested in...
Rigorous planning and a multidisciplinary team including database experts and healthcare specialists with local knowledge are vital to effective real-world evidence, white paper shows.
The latest submission and expedited review program news and highlights from our US FDA Performance Tracker.
The latest news about products accepted into US FDA expedited review programs.